BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27215356)

  • 1. The Impact of Liver and Renal Dysfunction on the Pharmacokinetics and Pharmacodynamics of Sedative and Analgesic Drugs in Critically Ill Adult Patients.
    Yogaratnam D; Ditch K; Medeiros K; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2016 Jun; 28(2):183-94. PubMed ID: 27215356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.
    Wagner BK; O'Hara DA
    Clin Pharmacokinet; 1997 Dec; 33(6):426-53. PubMed ID: 9435992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of drugs used in critically ill adults.
    Power BM; Forbes AM; van Heerden PV; Ilett KF
    Clin Pharmacokinet; 1998 Jan; 34(1):25-56. PubMed ID: 9474472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedation Analgesia and Neuromuscular Blockade in Pediatric Critical Care: Overview and Current Landscape.
    Zuppa AF; Curley MAQ
    Pediatr Clin North Am; 2017 Oct; 64(5):1103-1116. PubMed ID: 28941538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged infusion of sedatives and analgesics in adult intensive care patients: A systematic review of pharmacokinetic data reporting and quality of evidence.
    Tse AH; Ling L; Joynt GM; Lee A
    Pharmacol Res; 2017 Mar; 117():156-165. PubMed ID: 28012962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesia and sedation in the critically ill--a practical approach.
    Piccolo R; Lipman J; Hon H; Burrows RC
    S Afr J Surg; 1999 Feb; 37(1):15-20. PubMed ID: 10222804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients.
    Cheng V; Abdul-Aziz MH; Roberts JA; Shekar K
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):103-112. PubMed ID: 30582435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedation in the intensive care unit.
    McGrane S; Pandharipande PP
    Minerva Anestesiol; 2012 Mar; 78(3):369-80. PubMed ID: 22240616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedation in the critically ill patient.
    Costa MG; Chiarandini P; Della Rocca G
    Transplant Proc; 2006 Apr; 38(3):803-4. PubMed ID: 16647476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedation and pain management in critically ill adults.
    Arbour R
    Crit Care Nurse; 2000 Oct; 20(5):39-56; quiz 57-8. PubMed ID: 11878487
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment.
    Stöhr T; Colin PJ; Ossig J; Pesic M; Borkett K; Winkle P; Struys MMRF; Schippers F
    Br J Anaesth; 2021 Sep; 127(3):415-423. PubMed ID: 34246461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analgesia and sedation of mechanically ventilated critical patients].
    Ramos Delgado I; Samsó Sabé E
    Rev Esp Anestesiol Reanim; 2007 May; 54(5):302-12. PubMed ID: 17598721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
    Schenker S; Hoyumpa AM; Wilkinson GR
    Med Clin North Am; 1975 Jul; 59(4):887-96. PubMed ID: 238085
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology and pharmacokinetics of sedatives and analgesics.
    Horn E; Nesbit SA
    Gastrointest Endosc Clin N Am; 2004 Apr; 14(2):247-68. PubMed ID: 15121142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids.
    Devlin JW; Roberts RJ
    Crit Care Clin; 2009 Jul; 25(3):431-49, vii. PubMed ID: 19576523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.